chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired dose administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient).    No concomitant medications were reported.  The dates of vaccine administration were not reported and it was unknown whether patient took first, second or first and or second booster doses. The vial was initially stored in refrigerator on 7-Jun-2022. A total of 35 doses were given from 4 vials.  The dates in which vaccination were given from 1-Apr-2022, 5-Apr-2022, 8-Apr-2022, 6-Apr-2022, 11-Apr-2022,  12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 9-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. The vial did not undergo any temperature excursions. No treatment medications were reported.   This case was linked to-MODERNATX, INC.-MOD-2022-589423 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2022-589423:
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired dose administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient).    No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. The dates of administration of the vaccines was reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022.  The dates of vaccine administration were not reported and it was unknown whether patient took first, second or first and or second booster doses. No treatment medication information was provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Immunisation reaction, Peripheral swelling, Rash
Clinical narrative: With the second shot, he developed covid toe; He had a rash and swelling on his feet; He had a rash and swelling on his feet; very worn down for about three days after each shot; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (With the second shot, he developed covid toe), PERIPHERAL SWELLING (He had a rash and swelling on his feet), RASH (He had a rash and swelling on his feet) and FATIGUE (very worn down for about three days after each shot) in a 28-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    Concurrent medical conditions included Lyme's disease and Crohn's disease.   In June 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (With the second shot, he developed covid toe), PERIPHERAL SWELLING (He had a rash and swelling on his feet), RASH (He had a rash and swelling on his feet) and FATIGUE (very worn down for about three days after each shot). At the time of the report, IMMUNISATION REACTION (With the second shot, he developed covid toe) outcome was unknown and PERIPHERAL SWELLING (He had a rash and swelling on his feet), RASH (He had a rash and swelling on his feet) and FATIGUE (very worn down for about three days after each shot) had resolved.            No concomitant medication was reported.  Patient's wife reported that the patient received three Moderna COVID-19 vaccines. After the second shot, he developed 'covid toe' where he had a rash and swelling on his feet. He also developed this 'covid toe' after the booster shot but it was not as severe. The patient was also very worn down for about 3 days after each shot.  No treatment medication was reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.   This case was linked to MOD-2022-616834 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna vaccine) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna vaccine). No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates of administration of the vaccines was reported as 1-Apr-2022, 5-Apr-2022, 6-Apr2-022, 8-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 9-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. No treatment medication information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.  No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates of administration of the vaccines were reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022. The dates of vaccine administration were not reported, and it was unknown whether patient took first, second or first and or second booster doses. No treatment medication information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired doses administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (No adverse event) and EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patient) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, NO ADVERSE EVENT (No adverse event) and EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patient) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patient).    No concomitant medication information was provided.  The vial was initially stored in refrigerator on 7-Jun-2022.  The vial did not undergo any temperature excursions.  The dates of administration of the vaccines was reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022.  The dates of vaccine administration were not reported and it was unknown whether patient took first, second or first and or second booster doses.  No treatment medication information was provided
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient was administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine).    No concomitant medications were reported.  It was reported that the date of the patient vaccine administration was not known, and it was also unknown whether patient took first, second or first and or second booster doses. The vaccine was expired on 01-Apr-2022 and vials were initially stored in the refrigerator on 07-Jun-2022, they had not undergone any temperature excursions.  It was reported that the dates of vaccine administration were 01-Apr-2022, 05-Apr-2022,06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022.   No treatment medications were reported.   This case was linked to MOD-2022-589423 (Linked Report).; Sender's Comments:  MOD-2022-589423:Master case
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; expired dose administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.   In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired dose administered).    Concomitant medication was not provided. Number of doses per vials were 35 doses, 4 vials. The vial was initially stored in the refrigerator on 07-Jun-2022. Dates of administration of vaccines were 01-Apr-2022, 05-Apr-2022, 06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. Vial did not undergone any temperature excursion. Treatment information was not provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine).  No concomitant medication were reported. A total of 35 doses were given from 4 vials.  The vial was initially stored in refrigerator was on 07-Jun-2022.  The date for the patient vaccine administration was not known, and it was also unknown whether the patient took first, second or first and second booster doses.  It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates on which vaccinations were given from 01-Apr-22, 05-Apr-22, 08-Apr-22, 06-Apr-22, 11-Apr-22, 12-Apr-22, 13-Apr-22, 14-Apr-22, 22-Apr-22, 09-Jun-22, 10-Jun-22, 13-Jun-22, 18-Jun-22, and 22-Jun-22. The vial had not undergone any temperature excursions. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired Vaccine Used; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) and NO ADVERSE EVENT (No adverse event) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used).    No concomitant medication were reported. A total of 35 doses were given from 4 vials.  The vial was initially stored in refrigerator on 07-Jun-2022.  The dates in which vaccination were given are on 1-Apr-2022, 5-Apr-2022, 6-Apr-2022, 8-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 9-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. The vial didn't undergo any temperature excursion. No treatment information were provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired doses administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients).    No concomitant medication was provided.  It was reported that date the vial was initially stored in the refrigerator was 07 Jun 2022. Number of doses/vials were 35 doses and 4 vials.The vial did not undergo any temperature excursions. Date of administration of the vaccines: 1 Apr 2022, 5 Apr 2022, 6 Apr 2022, 8 Apr 2022, 11 Apr 2022, 12 Apr 2022, 13 Apr 2022, 14 Apr 2022, 22 Apr 2022, 9 Jun 2022,10 Jun   2022, 13 Jun 2022, 18 Jun 2022 and 22 Jun 2022.  Treatment medication was not provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Administered with an expired vaccine; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine).    No concomitant medications were reported. The vial was initially stored in refrigerator on 07-Jun-2022. The date for the patient vaccine administration was not known, and it was also unknown whether the patient took first, second or first and second booster doses.  It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates on which vaccinations were given from 01-Apr-22, 05-Apr-22, 08-Apr-22, 06-Apr-22, 11-Apr-22, 12-Apr-22, 13-Apr-22, 14-Apr-22, 22-Apr-22, 09-Jun-22, 10-Jun-22, 13-Jun-22, 18-Jun-22, and 22-Jun-22. The vial had not undergone any temperature excursions. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. The dates of administration of the vaccines were reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022. The dates of vaccine administration were not reported and it was unknown whether patient took first, second or first and or second booster doses. No treatment medication information was provided.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L21B) for COVID-19 vaccination. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine). No concomitant medication information was provided. The vial was initially stored in refrigerator on 07-Jun-2022. he vial did not undergo any temperature excursions. The patient was administered on any one of these dates (vaccine administration dates) of 01-Apr-2022, 05-Apr-2022, 06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired doses administered/ administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine).    No concomitant medications information was reported.  Number of doses/vials- 35 doses, 4 vials Date the vial was initially stored in the refrigerator- 07-Jun-2022 Expiration date: 01-Apr-2022  Date(s) of administration of the vaccine: 01-Apr-2022, 05-Apr-2022, 06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022.  The vial did not undergo any temperature excursions.  Pharmacy operations manager requested for any guidance to patients who had been administered with expired Moderna vaccine and queried if they should be revaccinated or not.  No treatment medications were provided.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired product administered.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Flushing, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Heart rate decreased, Hypotension, Injection site pain, Mobility decreased
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Hypotension-Severe, Additional Details: Caregiver also reported decreased heart rate and could not move arm.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Chills, body aches, fevers x3, no appetite, got up and violently threw up three times and then proceeded to have numbness and tingling in my upper and lower extremities along with extreme chills. The numbness in my fingers made it hard for me to hold my phone.  It would radiate from one extremity to the other and it did this for about 30-45 mins before it stopped.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Chills, body aches, fevers x3, no appetite, got up and violently threw up three times and then proceeded to have numbness and tingling in my upper and lower extremities along with extreme chills. The numbness in my fingers made it hard for me to hold my phone.  It would radiate from one extremity to the other and it did this for about 30-45 mins before it stopped.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Coagulopathy, Ear pain, Headache, Menstrual disorder
Clinical narrative: Headaches/ear pain/body aches/joint and nerve pain/muscle ache/menstrual disruption/clotting
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neuralgia, Pain
Clinical narrative: Headaches/ear pain/body aches/joint and nerve pain/muscle ache/menstrual disruption/clotting
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The vaccine was administered after a high temperature event reported according to the thermometer. Patient did not present any symptoms out of the ordinary. The experience was similar to his third dose.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid positive pt after 2 moderna vaccines
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The vaccine was administered after a high temperature event reported according to the thermometer. Patient did not present any symptoms out of the ordinary. The experience was similar to his third dose.
Age: 1.58
Sex: F
Vaccine: DTAPIPV, HEPA, HIBV, MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: In May of 2022, pt was given a dose of the Quadracel vaccine, which is not appropriate for this age. Pt had no immediate or long term reaction observed. This event was only discovered when pt transferred to another clinic and staff there noticed it while reviewing immunization records.
Age: 0.33
Sex: M
Vaccine: DTAPIPV, HIBV, PNC13, RV5
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: In May of 2022, pt was given a dose of Quadracel vaccine, which is not appropriate for this age. Pt had no immediate or long term reaction observed. This event was only discovered when pt transferred to another clinic and staff was reviewing vaccination records.
Age: 24.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Monkeypox, Pyrexia, Rash
Clinical narrative: Patient received Jynneos vaccine while symptomatic with monkeypox (rash and fevers). 3 weeks after symptom onset and one day after let out of isolation, patient woke up with new pox like lesions on his chest and back
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bronchitis, COVID-19, Chills, Cough
Clinical narrative: I was traveling and returned Saturday July 16, 2022, and I started with symptoms Friday July 22, I took a home test on July 23 and it came out Positive. I felt congestion, weakness, cough and chills, no fever (my body does not respond to fever, I have never had). I called my rheumatologist and she told me that she told me to go to the emergency room to get the antibodies and I went to the hospital and they gave me the treatment. I have continued with congestion, despite having the antibodies, on Friday July 29 I took the test again and it came out positive; So I called my doctor again to see if I could get out of isolation and he said yes, but at work they didn't allow me. I relapsed again and visited the doctor again because I had developed Bronchitis, this was Wednesday, July 27, and they gave me an antibiotic for 3 days and a cough suppressant for 6 days. But since I did not improve, the doctor gave me Molnupiravir and Cortisone again to deflate the Bronchi.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Impaired work ability, Malaise, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I was traveling and returned Saturday July 16, 2022, and I started with symptoms Friday July 22, I took a home test on July 23 and it came out Positive. I felt congestion, weakness, cough and chills, no fever (my body does not respond to fever, I have never had). I called my rheumatologist and she told me that she told me to go to the emergency room to get the antibodies and I went to the hospital and they gave me the treatment. I have continued with congestion, despite having the antibodies, on Friday July 29 I took the test again and it came out positive; So I called my doctor again to see if I could get out of isolation and he said yes, but at work they didn't allow me. I relapsed again and visited the doctor again because I had developed Bronchitis, this was Wednesday, July 27, and they gave me an antibiotic for 3 days and a cough suppressant for 6 days. But since I did not improve, the doctor gave me Molnupiravir and Cortisone again to deflate the Bronchi.
Age: 57.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Orthopoxvirus test positive, Pustule
Clinical narrative: Received Jynneos vaccine last week and now developed a single pustule on R forearm
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reaction.
Age: 31.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Blister, Exposure to communicable disease, Rash, Swelling face, Viral test
Clinical narrative: Received Jynneos vaccine on 7/27 then developed rash on 7/30. non tender, small bumps on forehead, multiple vesicular lesions on L arm, very small  not pruritic. Had contact with person infected with monkeypox
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 37.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Erythema, Induration, Pruritus, Swelling
Clinical narrative: Development of itching, redness and swelling about 3-4 days after the vaccination. Now with induration of about 4-6 cm in diameter. Treated with as needed ibuprofen. Started azithromycin on day 7 for possible cellulitis.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported on adverse reactions.
Age: 39.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Asthenia, Monkeypox, Orthopoxvirus test positive, Pyrexia, Rash
Clinical narrative: Patient received monkeypox vaccine on 7/22/22. Developed subjective fevers, weakness, followed by a rash 24 hours later, diffuse, pruritic on 7/25.  Previous sexual encounter 1 month prior to vaccination. Diagnosed with monkeypox.
Age: 39.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Rash pruritic
Clinical narrative: Patient received monkeypox vaccine on 7/22/22. Developed subjective fevers, weakness, followed by a rash 24 hours later, diffuse, pruritic on 7/25.  Previous sexual encounter 1 month prior to vaccination. Diagnosed with monkeypox.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Sinus disorder, Vaccine breakthrough infection
Clinical narrative: Developed breakthrough COVID despite having been fully vaccinated including 2 boosters with Moderna vaccine.  After taking Paxlovid, symptoms subsided.  After 14 days from initial diagnosis developed sinus issues, again tested positive for COVID suggesting COVID rebound.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 64.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site mass, Pain
Clinical narrative: Soreness for seven days and now small mass under the skin near the injection site.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Vaccination error
Clinical narrative: Vaccine administration error non viable vaccine
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient is under 50 years old and received second booster dose  without being immunocompromised
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Expired product administered
Clinical narrative: Vaccine that was administered on 8/3/22 expired on 7/31/22
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: COVID-19 PFIZER with an extended expiration date was given on 07/31/2022
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Product administration error, Product quality issue
Clinical narrative: Vaccine admin error, non viable vaccine
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I was having cough and congestion as well as a sore throat. I tested positive on the 28th of June wit a home COVID-19 test. Then I contacted my doctor and she prescribe the PAXLOVID but I didn't take it. I used over the counter medication MUCINEX, cough drops, and they helped with the cough and the irritation in my throat. It took about 11-12 days to get through the sickness. The thing that I did find strand was the person I believe gave me COVID-19 tested negative and I am not sure if she tested too soon or did the test wrong. This individual also shared a long road trip with another individual and they shared a room and this person was negative as well.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I was having cough and congestion as well as a sore throat. I tested positive on the 28th of June wit a home COVID-19 test. Then I contacted my doctor and she prescribe the PAXLOVID but I didn't take it. I used over the counter medication MUCINEX, cough drops, and they helped with the cough and the irritation in my throat. It took about 11-12 days to get through the sickness. The thing that I did find strand was the person I believe gave me COVID-19 tested negative and I am not sure if she tested too soon or did the test wrong. This individual also shared a long road trip with another individual and they shared a room and this person was negative as well.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: 14 y/o M patient brought to clinic by mother for Covid 19 booster.  Mother presented pt's CDC vaccine card with 2 doses of Pfizer from Sept 2021 written on it.  Pt received dose of purple cap 12&up pfizer today.  Upon entering vaccine into Pt's module in EMR, it was noted pt already had a booster in April 2021.   Mother was unaware of this April 2021 booster because father had brought the patient in without notifying mother. Mother was educated on s/s of myocarditis and advised to bring pt in for signs of illness/infection.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccine dose 1 given 2/25/2021 Pfizer lot # EN6203 Pt was hospitalized for Covid 19 7/29/2022-8/2/2022 at local Medical center.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reaction.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: large localized reaction noted approx. 12 hours after injection--10 cm erythema & induration surrounding injection site, nontender
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursions occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 1.0
Sex: M
Vaccine: MMRV, PNC13
Symptoms: Product administration error
Clinical narrative: Admin Error- Non Viable Vaccine
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: COVID-19 VACCINE WITH THE EXTENDED EXOIRATION DATE OF 07/31/2022 WAS GIVEN ON 08/02/2022
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test normal, Chest X-ray normal, Chest discomfort, Electrocardiogram normal
Clinical narrative: Chest heaviness started about 15 minutes after receiving vaccine. I felt like I was walking through mud. I felt weak. I continued with strong chest pressure/tightness for 3 months. I had my vital signs checked the day of the vaccine about a half hour later. Vitals were normal. I had been seen by a provider on August 31st after pressure not going away. An EKG, chest xray, and blood work were normal. I still felt terribly abnormal.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Chest heaviness started about 15 minutes after receiving vaccine. I felt like I was walking through mud. I felt weak. I continued with strong chest pressure/tightness for 3 months. I had my vital signs checked the day of the vaccine about a half hour later. Vitals were normal. I had been seen by a provider on August 31st after pressure not going away. An EKG, chest xray, and blood work were normal. I still felt terribly abnormal.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 28.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Exposure to communicable disease, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: He got his vaccine, had fever, fatigue, headaches, body aches.  Fever up to 102.  On Wednesday a friend of his called who he had close contact with and informed him that he was positive for monkey pox.  He is still having the same symptoms, and has been Tylenol for the fever.   He did call his doctor and has appointment today to be seen.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  patient reported no adverse reactions.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported on adverse reactions.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Dyspnoea, Hypotension, Hypoxia
Clinical narrative: MODERNA COVID #3 VACCINE GIVEN 10/28/21, LOT #076C21A; pt had a positive COVID test at Dialysis on 2/7/22; 2/8/22 pt brought to ED with increasing SOB; hypoxic; O2 supplementation; Remdesivir and Decadron; worsening respiratory status requiring BiPAP; pt was made a DNR; pt became unresponsive on dialysis and hypotensive; transitioned to comfort measures; pt expired in the hospital
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Respiratory disorder, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: MODERNA COVID #3 VACCINE GIVEN 10/28/21, LOT #076C21A; pt had a positive COVID test at Dialysis on 2/7/22; 2/8/22 pt brought to ED with increasing SOB; hypoxic; O2 supplementation; Remdesivir and Decadron; worsening respiratory status requiring BiPAP; pt was made a DNR; pt became unresponsive on dialysis and hypotensive; transitioned to comfort measures; pt expired in the hospital
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine. No temperature excursions occurred. Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration."  No adverse reactions reported.
Age: 16.0
Sex: M
Vaccine: DTAP, HEP, IPV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: On 8/3/2022 @ 0840, I went into vaccine room and pulled up patient's record in system to check what vaccines were due. After checking, I went to vaccine refrigerator and pulled required vaccines. I called patient to check medications and allergies. Then I pulled each vaccine. I went into EHR and put each vaccine in by lot number and expiration. Patient called in and each vaccine was given. I went to my desk and looked at reconciliation so that I could order COVID vaccines. At this point I noticed the MMR vaccine I administered was high-lighted in red. I went back and double-checked the expiration date and it was 7/30/2022. No treatment was needed. 1330- Patient called and no adverse reactions verbalized.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 1/18/2021, 2/12/2021 and 12/22/2021. Positive on 7/28/2022.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Fibrin D dimer, Intracardiac thrombus, Pulmonary thrombosis
Clinical narrative: Blood clots bilateral lungs and surrounding heart
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Was administered four days after expiration
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Hyperhidrosis
Clinical narrative: 07/21/2022  I woke up early and was sweating through my clothes. My clothes were damp.  I felt cold.  For a  half an hour to an hour I continued to sweat and feel cold. This continued for about 3 times a week.  I have an appointment to see my doctor about this.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, COVID-19, Inflammation, Psoriatic arthropathy, Rheumatoid arthritis
Clinical narrative: Contracted Covid on 4/18/22. On 5/19/22 blood tests confirmed rheumatoid &/or Soriatic arthritis.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Moderna 2/24/21, 3/25/21. Positive on 8/1/22